Global Urethral Strictures Market Research Report Information: Type (AUS, PUS) Condition (Hypospadias & Epispadias) Cause (Idiopathic) Treatment (Urethroplasty) Gender (Male, Female) End-user (Ambulatory Surgical Centers) – Forecast Till 2023

Published - Feb 2019 | Category - Healthcare | No. of Pages - 265 | Published By - Market Research Future

Table of Contents:

Global Urethral Strictures Market- Forecast 2023

1 Executive Summary

2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure

3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model

4 Market Dynamics
4.1 Drivers
4.1.1 Introduction
4.1.2 Increasing prevalence of urethral strictures
4.1.3 Rising cases of urolithiasis in the adult population
4.1.4 Growing occurrence of urinary incontinence
4.2 Restraints
4.2.1 High cost of surgical procedure
4.2.2 High rate of complications
4.3 Opportunities
4.3.1 Technologically advanced products

5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Research &Development
5.2.2 Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
5.3 Epidemiology of Urethral Stricture

6 Global Urethral Stricture Market, By Type
6.1 Introduction
6.1.1 Posterior Urethral Stricture
6.1.2 Anterior Urethral Stricture

7 Global Urethral Stricture Market, By Condition
7.1 Introduction
7.1.1 Hypospadias & Epispadias
7.1.2 Urinary Incontinence

8 Global Urethral Stricture Market, By Cause
8.1 Introduction
8.1.1 Iatrogenic
8.1.2 Idiopathic
8.1.3 Infection-induced
8.1.4 Trauma

9 Global Urethral Stricture Market, By Treatment
9.1 Introduction
9.1.1 Urethral Dilation
9.1.2 Direct Vision Internal Urethrotomy (DVIU)
9.1.3 Urethroplasty

10 Global Urethral Stricture Market, By Gender
10.1 Introduction
10.1.1 Male
10.1.2 Female

11 Global Urethral Stricture Market, By End User
11.1 Introduction
11.1.1 Hospitals
11.1.2 Urologic Clinics
11.1.3 Ambulatory Surgical Centers

12 Global Urethral Stricture Market, By Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 U.S.
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 UK
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 Middle East
12.5.2 Africa

13 Competitive Landscape
13.1 Company Market Share Analysis
13.1.1 Introduction
13.2 Competitive Landscape
13.2.1 Introduction
13.3 Key Developments
13.3.1 Global Urethral stricture Market: Key Development

14 Company Profiles
14.1 SRS Medical
14.1.1 Company Overview
14.1.2 Financial Overview:
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 JenaSurgical GmbH
14.2.1 Company Overview
14.2.2 Financial Overview:
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Boston Scientific Corporation
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Cook Medical
14.4.1 Company Overview
14.4.2 Financial Overview:
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key strategy
14.5 Stryker Corporation
14.5.1 Company Overview
14.5.2 Financial Overview:
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key strategy
14.6 KARL STORZ GmbH & Co. KG
14.6.1 Company Overview
14.6.2 Financial Overview:
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key strategy
14.7 Olympus Corporation
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 PENTAX Medical
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Healthtronics, Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Allium Medical Solutions
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 UROMED
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
14.12 Richard Wolf GmbH
14.12.1 Company Overview
14.12.2 Financial Overview
14.12.3 Products Offering
14.12.4 Key Developments
14.12.5 SWOT Analysis
14.12.6 Key Strategy
14.13 Bard Medical
14.13.1 Company Overview
14.13.2 Financial Overview
14.13.3 Products Offering
14.13.4 Key Developments
14.13.5 SWOT Analysis
14.13.6 Key Strategy
14.14 Lumenis Ltd.
14.14.1 Company Overview
14.14.2 Financial Overview
14.14.3 Products Offering
14.14.4 Key Developments
14.14.5 SWOT Analysis
14.14.6 Key Strategy
14.15 Mukocell
14.15.1 Company Overview
14.15.2 Financial Overview:
14.15.3 Products Offering
14.15.4 Key Developments
14.15.5 SWOT Analysis
14.15.6 Key Strategy

15 Appendix
15.1 Discussion Blue Print

 

Quick Buy